Zydus Wellness net sales up by 113.7% in Q3 FY26
Glucon-D maintained its leadership position with a 59% MAT market share
Glucon-D maintained its leadership position with a 59% MAT market share
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
This deal marks a major step for Alteogen as it pushes its Hybrozyme platform deeper into the oncology market
India in the Changing Landscape of Life-Sciences Research & Development
Artificial intelligence coupled with laboratory automation will transform how scientific work is performed
The company previously completed a $150 million venture investment, acquisition, and recapitalization
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
Applications include detailed scientific rationale and supporting clinical evidence
Subscribe To Our Newsletter & Stay Updated